49569-46-2

Basic information

• Product Name: 1-benzyl-5-bromohexahydroazepin-4-one hydrobromide
• Synonyms: 1-benzyl-5-bromohexahydroazepin-4-one hydrobromide
• CAS NO: 49569-46-2
• Molecular Weight: 363.092
• Mol File: 49569-46-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-benzyl-5-bromohexahydroazepin-4-one hydrobromide(CAS DataBase Reference)
• NIST Chemistry Reference: 1-benzyl-5-bromohexahydroazepin-4-one hydrobromide(49569-46-2)
• EPA Substance Registry System: 1-benzyl-5-bromohexahydroazepin-4-one hydrobromide(49569-46-2)

Safety Data

• Hazardous Substances Data: 49569-46-2(Hazardous Substances Data)

Upstream product

• 23583-21-3 ethyl-3-benzylamino propionate 
• 100-46-9 benzylamine 
• 1164-14-3 ethyl 4-(N-benzyl-N-(2-ethoxycarbonylethyl))aminobutyrate 
• 1208-76-0 1-benzyl-1,2,3,5,6,7-hexahydroazepine-4-one hydrochloride 
• 1208-75-9 1-benzylazepan-4-one 

Downstream Products

• 1158918-82-1 6-benzyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine-hydrochloride 
• 1159094-24-2 6-benzyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine 
• 303021-31-0 6-Benzyl-4,5,7,8-tetrahydro-1H,6H-imidazo[4,5-d]azepine 

Relevant articles and documents

NOVEL COMPOUNDS

The present invention relates to new CGRP-antagonists of general formula I wherein U, V, X, Y, R1, R2, R3 and R4 are defined as mentioned in the description, the tautomers thereof, the isomers thereof, the diastereomers thereof, the enantiomers thereof, the hydrates thereof, the mixtures thereof and the salts thereof as well as the hydrates of the salts, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, medicaments containing these compounds, the use thereof and processes for the preparation thereof.

Substituted imidazoles, their preparation and use

Disclosed is a novel class of substituted imidazole compounds, pharmaceutical compositions containing them and uses of these compounds in the treatment and/or prevention of diseases and disorders related to the histamine H3 receptor. More particularly, th